Fingerprint
Dive into the research topics of 'Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: A randomized, double-blind, multicenter Phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically